FDA panel considers loosening regulations on certain unapproved peptides

4 sources covered this ⚠ Left-only compare →

STAT’s coverage frames the vote as a “win for RFK Jr.” and highlights the narrow margin of the decision, while CBS News emphasizes the policy shift, leading with “loosening restrictions” and describing the peptides as “short chains of…

Jul 24, 2026 · 4:53 PM UTC ·1 min read · 0 reactions · 0 comments · 2 views

FDA panel considers loosening regulations on certain unapproved peptides

The Food and Drug Administration advisory panel is holding a second day of meetings on whether to loosen restrictions on certain unapproved peptide drugs. The panel voted Thursday to broaden access to four peptides. KFF Health News' Amy Maxmen has more.

How this story was covered

2 outlets in our directory ran this story, first to last over 21 hours. All of the coverage we found sits in one bucket: centre. That one-sidedness is itself worth noticing.

Centre · 1

▪ STAT+: In win for RFK Jr., FDA advisory panel narrowly votes to allow compounding of unapproved peptides — STAT

About this source

CBS News — Top files mainly under news. We currently carry 1,584 of its stories.

All CBS News — Top coverage →

Original article

CBS News — Top

Read full at CBS News — Top →

Anonymous · no account needed

Discussion

0 comments

FDA panel considers loosening regulations on certain unapproved peptides

Discussion

More from CBS News — Top